Role of anti-pseudomonal antibiotics in the emergence of Stenotrophomonas maltophilia in cystic fibrosis patients

Eur J Clin Microbiol Infect Dis. 1996 May;15(5):402-5. doi: 10.1007/BF01690098.

Abstract

A retrospective case-control study of 12 patients positive for Stenotrophomonas maltophilia and 24 age-sex-matched controls revealed that in the year prior to initial isolation, colonised patients spent more days in hospital and received more days of oral ciprofloxacin, intravenous anti-pseudomonal antibiotics, and nebulised aminoglycosides. They were also more likely to have grown Pseudomonas aeruginosa at some time in the past, despite there being no difference in current chronic infection with this organism. The role of anti-pseudomonal antibiotics in promoting Stenotrophomonas maltophilia colonisation in cystic fibrosis is discussed.

Publication types

  • Clinical Trial

MeSH terms

  • Adolescent
  • Aminoglycosides
  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use*
  • Case-Control Studies
  • Child
  • Child, Preschool
  • Chronic Disease
  • Cystic Fibrosis / complications*
  • Female
  • Humans
  • Male
  • Microbial Sensitivity Tests
  • Pseudomonas Infections* / complications
  • Pseudomonas Infections* / drug therapy
  • Pseudomonas aeruginosa / drug effects*
  • Pseudomonas aeruginosa / isolation & purification
  • Retrospective Studies
  • Treatment Outcome

Substances

  • Aminoglycosides
  • Anti-Bacterial Agents